open federal funding opportunity

DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Development Award

Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Development Award (TDA) supports research ranging from preclinical validation of therapeutic leads through U.S. Food and Drug Administration (FDA) Investigational New Drug (IND)-enabling studies. The proposed stud…

Agency

Defense Health Agency Contracting Activity - DHACA

Opportunity number

HT942526ALSRPTDA